A patent battle between Juno Pharmaceuticals and Bristol-Myers Squibb over the blockbuster drug Revlimid has seen both sides suffer early losses, with a judge dismissing strike out and summary dismissal applications by the drug makers.
The University of New South Wales has been taken to court by a former tenured professor who alleges she was terminated after making complaints about discrimination against female academics, bullying and misuse of her intellectual property.
Boston Scientific has been hit with second class action on behalf of women who were implanted with allegedly defective pelvic mesh devices, just two weeks after the Full Court tossed an appeal to a landmark ruling that put Johnson & Johnson on the hook for millions in damages for failing to adequately warn patients about the risks the products carry.
A judge has issued an injunction temporarily barring use of the RestQ trade mark on sleep products sold by Martin & Pleasance because of a “disturbing” number of similarities with the marketing and appearance of an established competitor’s Rescue natural sleep aid product.
Victorian public healthcare provider Peninsula Health has been hit with a class action brought by junior doctors who claim they were deliberately unpaid despite working a significant amount of overtime each week.
Women’s activewear company Lorna Jane has defended ACCC allegations that it represented to consumers during that height of the coronavirus pandemic that its activewear would protect them from viruses including COVID-19, saying it had a reasonable and proper basis for making the claims.
Swiss drug giant Novartis has sued generic drug maker Pharmacor to halt its launch of a generic version of the company’s top-selling MS drug Gilenya.
Generic pharmaceutical company Sandoz has hit back in an intellectual property lawsuit by Merck Sharp & Dohme, filing a cross-claim that seeks to undo an extension of time granted to the US drug manufacturer for a patent relating to its multibillion dollar Januvia and Janumet diabetes drugs.
The Full Federal Court has tossed an appeal by Johnson & Johnson unit Ethicon challenging a landmark decision that put it on the hook for paying damages to 10,000 women who suffered injury through defects in its prolapse mesh and incontinence tape implants.
Medical device giant Boston Scientific faces a class action on behalf of women who allege they suffered debilitating injuries from the company’s pelvic mesh products.